Genometrix
Executive Summary
Genometrix has developed a protoype molecular imaging system it believes can demonstrate single molecule detection at a 10-fold throughput advantage over conventional technologies used in sequence-, hybridization-, and amplification-based DNA research and diagnostics protocols.
You may also be interested in...
GE-Genometrix: Dx Imaging Meets Genomics
In an intriguing deal, GE Medical Systems, one of the largest suppliers of MRI and PET equipment, is teaming up with Genometrix, Inc., an applied genomics company in a research collaboration that will combine molecular imaging techniques with genetic probes to develop technologies for detecting and quantifying risk levels for diseases such as breast and prostate cancer.
US High Court Punts On ‘Objective Falsity’ FCA Standard
Can a false-claims suit be filed if doctors have different opinions about whether a treatment was necessary? The Supreme Court won’t say.
Warning Letter Close-Outs – February 2021
No device-related close-out letters were released by the US FDA last month.
Need a specific report? 1000+ reports available
Buy Reports